Department of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu 210008, P.R. China; Institute of Brain Sciences, Nanjing University, Nanjing, Jiangsu 210093, P.R. China; Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu 210008, P.R. China; Jiangsu Province Stroke Center for Diagnosis and Therapy, Nanjing, Jiangsu 210008, P.R. China; Nanjing Neurology Clinic Medical Center, Nanjing, Jiangsu 210008, P.R. China.
Department of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu 210008, P.R. China; Institute of Brain Sciences, Nanjing University, Nanjing, Jiangsu 210093, P.R. China; Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu 210008, P.R. China; Jiangsu Province Stroke Center for Diagnosis and Therapy, Nanjing, Jiangsu 210008, P.R. China; Nanjing Neurology Clinic Medical Center, Nanjing, Jiangsu 210008, P.R. China.
Mol Ther. 2021 Sep 1;29(9):2873-2885. doi: 10.1016/j.ymthe.2021.04.025. Epub 2021 Apr 23.
Dysregulated long non-coding RNAs (lncRNAs) have been shown to contribute to the pathogenesis of ischemic stroke. However, the potential role of lncRNAs in post-stroke microglial activation remains largely unknown. Here, we uncovered that lncRNA-U90926 was significantly increased in microglia exposed to ischemia/reperfusion both in vivo and in vitro. In addition, adenovirus-associated virus (AAV)-mediated microglial U90926 silencing alleviated neurological deficits and reduced infarct volume in experimental stroke mice. Microglial U90926 knockdown could reduce the infiltration of neutrophils into ischemic lesion site, which might be attributed to the downregulation of C-X-C motif ligand 2 (CXCL2). Mechanistically, U90926 directly bound to malate dehydrogenase 2 (MDH2) and competitively inhibited the binding of MDH2 to the CXCL2 3' untranslated region (UTR), thus protecting against MDH2-mediated decay of CXCL2 mRNA. Taken together, our study demonstrated that microglial U90926 aggravated ischemic brain injury via facilitating neutrophil infiltration, suggesting that U90926 might be a potential biomarker and therapeutic target for ischemic stroke.
失调的长非编码 RNA(lncRNA)已被证明有助于缺血性中风的发病机制。然而,lncRNA 在中风后小胶质细胞激活中的潜在作用在很大程度上尚不清楚。在这里,我们发现在体内和体外,小胶质细胞暴露于缺血/再灌注时,lncRNA-U90926 显著增加。此外,腺相关病毒(AAV)介导的小胶质细胞 U90926 沉默减轻了实验性中风小鼠的神经功能缺损并减少了梗死体积。小胶质细胞 U90926 敲低可减少中性粒细胞浸润到缺血性病变部位,这可能归因于 C-X-C 基序配体 2(CXCL2)的下调。机制上,U90926 直接与苹果酸脱氢酶 2(MDH2)结合,并竞争性抑制 MDH2 与 CXCL2 3'非翻译区(UTR)的结合,从而防止 MDH2 介导的 CXCL2 mRNA 衰减。总之,我们的研究表明,小胶质细胞 U90926 通过促进中性粒细胞浸润加重缺血性脑损伤,表明 U90926 可能是缺血性中风的潜在生物标志物和治疗靶点。